Endothelin converting enzyme-1 gene expression in the kidney of spontaneously hypertensive rats

Hypertension

Volumn 30, Issue 6, 1997, Pages 1591-1597

  Disashi, Tumba ^a   Nonoguchi, Hiroshi ^a   Iwaoka, Taisuke ^a   Naomi, Shojiro ^a   Nakayama, Yushi ^a   Shimada, Kohei ^b   Tanzawa, Kazuhiko ^a   Tomita, Kimio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

Endothelin 1; Nephron; Reverse transcription polymerase chain reaction; Sodium

Indexed keywords

ENDOTHELIN CONVERTING ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; DOG; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM RETENTION;

EID: 0030696259     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.6.1591     Document Type: Article

References (40)

1. Rettig R, Schmitt B, Pelzl B, Speck T. The kidney and primary hypertension: contributions from renal transplantation studies in animals and humans. J Hypertens. 1993;11:883-891.
2. Harrap S, Doyle A. Renal haemodynamics and total body sodium in immature spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens. 1986;4(suppl 3):S249-S252.
3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
4. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-415. Review.
5. King A, Brenner B, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989;256:F1051-F1058.
6. Yamada K, Yoshida S. Role of endogenous endothelin on renal functions in rats. Am J Physiol. 1991;260:F34-F38.
7. Lerman A, Hildebrand F, Aarhus L, Burnett J. Endothelin has biological actions at pathophysiological concentrations. Circulation. 1991;83:1808-1814.
8. Clozel M, Breu V, Burri K, Cassai J-M, Fischli W, Gray GA, Hirth G, Loffler B-M, Muller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
9. Rabelink T, Kaasjaager K, Boer P, Stroes E, Braam B, Komnas. Effect of ET-1 on renal function in humans: implication for physiology and pathophysiology. Kidney Int. 1994;46:376-381.
10. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension. 1990;15:493-496.
11. Saito Y, Nakao K, Mokoyama M, Shirakami G, Itoh H, Yamada T, Arai H, Hosoda K, Suga S-I, Jougasaki M, Ogawa Y, Nakajima S, Ueda M, Imura H. Application of monoclonal antibodies for endothelin to hypertensive research. Hypertension. 1990;15:734-738.
12. Kohno M, Yasunari K, Murakawa K-I, Yokokawa K, Horio T, Fukui T, Takeda T. Plasma immunoreactive endothelin in essential hypertension. Am J Med. 1990;88:614-618.
13. Hirata Y, Hayakawa H, Suzuki E, Omata M. Does endothelin work as an intrarenal mechanism to alter pressure natriuresis in spontaneously hypertensive rats? J Hypertens. 1994;12:251-257.
14. Hughes A, Cline R, Kohan D. Alterations in renal endothelin-1 production in the spontaneously hypertensive rat. Hypertension. 1992;20:666-673.
15. Ohno A, Naruse M, Kato S, Hosaka M, Naruse K, Demura H, Sugino N. Endothelin-specific antibodies decrease blood pressure and increase glomerular filtration rate and renal plasma flow in spontaneously hypertensive rats. J Hypertens. 1992;10:781-785.
16. Kato T, Kassab S, Wilkins FJ, Kirchner K, Reiser J, Granger J. Endothelin antagonists improve renal function in spontaneously hypertensive rats. Hypertension. 1995;25:883-887.
17. Abassi Z, Klein H, Golomb E, Keiser H. Urinary endothelin: a possible biological marker of renal damage. Am J Hypertens. 1993; 6:1046-1054.
18. Shimada K, Takahashi M, Tanzawa K. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem. 1994;269:18275-18278.
19. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell. 1994; 78:473-485.
20. Terada Y, Tomita K, Nonoguchi H, Marumo F. Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. J Clin Invest. 1992;90:107-112.
21. Morel F, Chabardes D, Imbert-Teboul M. Methodology for enzymatic studies of isolated tubular segment: adenylate cyclase. Methods Pharmacol. 1978;4B:297-323.
22. Higuchi R, Krummel B, Saiki RK. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucl Acids Res. 1988;16:7351-7367.
23. Laghmani K, Borensztein P, Ambuhl P, Froissart M, Bichara M, Moe OW, Alpern RJ, Paillard M. Chronic metabolic acidosis enhances NHE-3 protein abundance and transport activity in the rat thick ascending limb by increasing NHE-3 mRNA. J Clin Invest. 1997;99:24-30.
24. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci U S A. 1990;87: 2725-2729.
25. Nonoguchi H, Owada A, Kobayashi N, Takayama M, Terada Y, Koike J, Ujiie K, Marumo F, Sakai T, Tomita K. Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts. J Clin Invest. 1995;96:1768-1778.
26. Kohzuki M, Johnston CI, Chai SY, Casley DJ, Mendelsohn FAO. Localization of endothelin receptors in rat kidney. Eur J Pharmacol. 1989;160:193-194.
27. Oishi R, Nonoguchi H, Tomita K, Marumo F. Endothelin-1 inhibits vasopressin-stimulated osmotic water permeability in inner medullary collecting duct of rat. Am J Physiol. 1991;261:F951-F956.
28. Tomita K, Nonoguchi H, Terada Y, Marumo F. Effects of ET-1 on water and chloride transport in cortical collecting ducts of the rat. Am J Physiol. 1993;264:F690-F696.
29. Garcia NH, Garvin JL. Endothelin's biphasic effect on fluid absorption in the proximal straight tubule and its inhibitory cascade. J Clin Invest. 1994;93:2572-2577.
30. Kohno M, Murakawa K, Horio T, Yokokawa K, Yasunari K, Fukui T, Takeda T. Plasma immunoreactive endothelin-1 in experimental malignant hypertension. Hypertension. 1991;18:93-100.
31. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F. Presence of immunoreactive endothelin in human plasma. FEBS Lett. 1989;245: 164-166.
32. Niranjan V, Telemaque S, DeWit D, Gerard RD, Yanagisawa M. Systemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats. J Clin Invest. 1996;98:2364-2372.
33. Loutzenhiser R, Epstein M, Hayashi K, Horton C. Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol. 1990;258:F61-F68.
34. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC. Mesangial cell, glomerular and renal vascular responses to endothelin in rat kidney: elucidation of signal transduction pathways. J Clin Invest. 1989;83:336-342.
35. Lu S, Mattson DL, Cowlery AW Jr. Renal medullary captopril delivery lowers blood pressure in spontaneously hypertensive rats. Hypertension. 1994;23:337-345.
36. Larson TS, Lockhart JC. Restoration of vasa recta hemodynamics and pressure natriuresis in SHR by L-arginine. Am J Physiol. 1995; 268:F907-F912.
37. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-536. Review.
38. McMahon E, Palomo M, Moore W. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1991; 17(suppl 7):S29-S33.
39. Vemulapalli S, Watkins R, Brown A, Cook J, Bernardino V, Chiu P. Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats. Life Sci. 1993;53:783-793.
40. Gomez-Garre D, Largo R, Lui X-H, Gutierrez S, Lopez-Armada MJ, Palacios I, Egido J. An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int. 1996;50:962-972.